Drug Discovery Technologies Global Market Outlook 2016-2022
ReportsWeb.com published “Drug Discovery Technologies Global Market” from its database. This report Strategic recommendations in key business segments based on the market estimations. This report Supply chain trends mapping the latest technological advanc
(EMAILWIRE.COM, January 17, 2018 ) According to Publisher, the Global Drug Discovery Technologies market is estimated at $XX million in 2015 and is expected to reach $XX million by 2022 growing at a CAGR of XX% from 2015 to 2022. Rise in new diseases and growing demand for therapeutics in various diseases are the factors driving the market growth. Stringent regulations and high initial cost associated with drug discovery are the factors hampering the market. Discovering drugs for diseases like Parkinson disease, cancer, nervous disorders is the opportunity for the market growth.
For more information about this report: http://www.reportsweb.com/drug-discovery-technologies-global-market-outlook-2016-2022
Some of the key players in the market include Bayer Healthcare AG, Roche Holding AG, Boehringer Ingelheim GmbH, Illumina Inc., Millennium Pharmaceuticals, Inc., Abbott Laboratories, Beckman Coulter Inc., Aviva Biosciences Corp., Bio-Rad Laboratories, Inc., Novartis AG, Charles River Laboratories International, Inc., Evotec AG, Merck & Co., Inc., Viva Biotech Ltd, Sri Biosciences, GE Healthcare Ltd., Qiagen N.V. and Quantum Pharmaceuticals.
Technologies Covered:
- DNA & Protein Microarrays
- High Throughput Screening
- Genomics
- Biochips
- Proteomic Technologies
- Microfluidics
- Metabolomics
- Pharmacogenomics
- Gel Electrophoresis
- Bioanalytical Instruments
- Chromatography
- Bioinformatics
- QPCR
- Combinatorial Chemistry
- Mass Spectrometry
- Nanotechnology
- RNAi
- Nucleic Acid Isolation
- Protein
- Epigenetics
- Cell Based Assays
- Laboratory Information Management Systems
Applications Covered:
- Parkinson’s disease
- Cancer
- Central Nervous System Disorders
- Cardiovascular Diseases
- Other Applications
End Users Covered:
- Biopharmaceutical Companies
- Research Institutes
- Biotech Companies
- Pharmaceutical Companies
Request Sample Copy at http://www.reportsweb.com/inquiry&RW0001565011/sample
Regions Covered:
- North America
o US
o Canada
o Mexico
- Europe
o Germany
o France
o Italy
o UK
o Spain
o Rest of Europe
- Asia Pacific
o Japan
o China
o India
o Australia
o New Zealand
o Rest of Asia Pacific
- Rest of the World
o Middle East
o Brazil
o Argentina
o South Africa
o Egypt
What our report offers:
- Market share assessments for the regional and country level segments
- Market share analysis of the top industry players
- Strategic recommendations for the new entrants
- Market forecasts for a minimum of 7 years of all the mentioned segments, sub segments and the regional markets
- Market Trends (Drivers, Constraints, Opportunities, Threats, Challenges, Investment Opportunities, and recommendations)
- Strategic recommendations in key business segments based on the market estimations
- Competitive landscaping mapping the key common trends
- Company profiling with detailed strategies, financials, and recent developments
- Supply chain trends mapping the latest technological advancements
Company Profiling
10.1 Bayer Healthcare AG
10.2 Roche Holding AG
10.3 Boehringer Ingelheim GmbH
10.4 Illumina Inc.
10.5 Millennium Pharmaceuticals, Inc.
10.6 Abbott Laboratories
10.7 Beckman Coulter Inc.
10.8 Aviva Biosciences Corp.
10.9 Bio-Rad Laboratories, Inc.
10.10 Novartis AG
10.11 Charles River Laboratories International, Inc.
10.12 Evotec AG
10.13 Merck & Co., Inc.
10.14 Viva Biotech Ltd
10.15 Sri Biosciences
10.16 GE Healthcare Ltd.
10.17 Qiagen N.V.
10.18 Quantum Pharmaceuticals
Inquire before Buying at http://www.reportsweb.com/inquiry&RW0001565011/buying
For more information about this report: http://www.reportsweb.com/drug-discovery-technologies-global-market-outlook-2016-2022
Some of the key players in the market include Bayer Healthcare AG, Roche Holding AG, Boehringer Ingelheim GmbH, Illumina Inc., Millennium Pharmaceuticals, Inc., Abbott Laboratories, Beckman Coulter Inc., Aviva Biosciences Corp., Bio-Rad Laboratories, Inc., Novartis AG, Charles River Laboratories International, Inc., Evotec AG, Merck & Co., Inc., Viva Biotech Ltd, Sri Biosciences, GE Healthcare Ltd., Qiagen N.V. and Quantum Pharmaceuticals.
Technologies Covered:
- DNA & Protein Microarrays
- High Throughput Screening
- Genomics
- Biochips
- Proteomic Technologies
- Microfluidics
- Metabolomics
- Pharmacogenomics
- Gel Electrophoresis
- Bioanalytical Instruments
- Chromatography
- Bioinformatics
- QPCR
- Combinatorial Chemistry
- Mass Spectrometry
- Nanotechnology
- RNAi
- Nucleic Acid Isolation
- Protein
- Epigenetics
- Cell Based Assays
- Laboratory Information Management Systems
Applications Covered:
- Parkinson’s disease
- Cancer
- Central Nervous System Disorders
- Cardiovascular Diseases
- Other Applications
End Users Covered:
- Biopharmaceutical Companies
- Research Institutes
- Biotech Companies
- Pharmaceutical Companies
Request Sample Copy at http://www.reportsweb.com/inquiry&RW0001565011/sample
Regions Covered:
- North America
o US
o Canada
o Mexico
- Europe
o Germany
o France
o Italy
o UK
o Spain
o Rest of Europe
- Asia Pacific
o Japan
o China
o India
o Australia
o New Zealand
o Rest of Asia Pacific
- Rest of the World
o Middle East
o Brazil
o Argentina
o South Africa
o Egypt
What our report offers:
- Market share assessments for the regional and country level segments
- Market share analysis of the top industry players
- Strategic recommendations for the new entrants
- Market forecasts for a minimum of 7 years of all the mentioned segments, sub segments and the regional markets
- Market Trends (Drivers, Constraints, Opportunities, Threats, Challenges, Investment Opportunities, and recommendations)
- Strategic recommendations in key business segments based on the market estimations
- Competitive landscaping mapping the key common trends
- Company profiling with detailed strategies, financials, and recent developments
- Supply chain trends mapping the latest technological advancements
Company Profiling
10.1 Bayer Healthcare AG
10.2 Roche Holding AG
10.3 Boehringer Ingelheim GmbH
10.4 Illumina Inc.
10.5 Millennium Pharmaceuticals, Inc.
10.6 Abbott Laboratories
10.7 Beckman Coulter Inc.
10.8 Aviva Biosciences Corp.
10.9 Bio-Rad Laboratories, Inc.
10.10 Novartis AG
10.11 Charles River Laboratories International, Inc.
10.12 Evotec AG
10.13 Merck & Co., Inc.
10.14 Viva Biotech Ltd
10.15 Sri Biosciences
10.16 GE Healthcare Ltd.
10.17 Qiagen N.V.
10.18 Quantum Pharmaceuticals
Inquire before Buying at http://www.reportsweb.com/inquiry&RW0001565011/buying
Contact Information:
ReportsWeb.com
Rajat Sahni
Tel: +1-646-491-9876
Email us
----
This press release is posted on EmailWire.com -- a global newswire that provides Press Release Distribution Services with Guaranteed Results
ReportsWeb.com
Rajat Sahni
Tel: +1-646-491-9876
Email us
----
This press release is posted on EmailWire.com -- a global newswire that provides Press Release Distribution Services with Guaranteed Results